BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

11.42
Delayed Data
As of May 22
 +0.12 / +1.06%
Today’s Change
7.85
Today|||52-Week Range
14.62
-6.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$828.2M

Company Description

BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in the pathogenesis of diseases with its focus on therapeutic areas with unmet medical needs. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company was founded in 1986 and is headquartered in Birmingham, AL.

Contact Information

BioCryst Pharmaceuticals, Inc.
2190 Parkway Lake Drive
Birmingham Alabama 35244
P:(205) 444-4600
Investor Relations:
(919) 859-7910

Employees

Shareholders

Other institutional54.22%
Mutual fund holders36.85%
Individual stakeholders19.27%

Top Executives

Jon P. StonehousePresident, Chief Executive Officer & Director
Thomas R. StaabChief Financial Officer, Treasurer, CAO & SVP
William P. SheridanChief Medical Officer & Senior Vice President
Lynne PowellChief Commercial Officer & Senior Vice President
Alane P. BarnesSecretary, Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account